TREM1 and COVID-19: Given that SARS-CoV-2 induces a hyper-inflammatory response, we hypothesized that in COVID-19 patients, the virus could trigger activation and up-regulation of TREM-1 in the cell surface and, subsequently, shedding in the soluble form (sTREM-1) by metalloproteinase activity.